Marion Mafham

Clinical Research Fellow, CTSU

Honorary Consultant Nephrologist, Oxford Kidney Unit

Marion Mafham studied medicine at the University of Edinburgh (1992-1998). In 2003, she joined the Renal Studies Group at CTSU for 3 years as a research fellow, working on the Study of Heart and Renal Protection. During this time she completed an MD thesis examining the relationship between measures of kidney function and cardiovascular risk factors and cardiovascular events. After completing her specialist training in Nephrology, she returned to CTSU in 2013, to work with Professor Jane Armitage in the Heart Studies Group. She is also an Honorary Consultant Nephrologist in the Oxford University Hospitals NHS trust.

Recent publications

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Journal article

RECOVERY Collaborative Group None. et al, (2020), N Engl J Med
LDL-cholesterol reduction in chronic kidney disease: options beyond statins.
Journal article

Goonasekera MA. et al, (2020), Curr Opin Nephrol Hypertens
Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.
Journal article

RECOVERY Collaborative Group None. et al, (2020), N Engl J Med
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Journal article

LANDRAY M. et al, (2020), New England Journal of Medicine
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.
Journal article

Horby P. et al, (2020)

More publications